Related Experiment Video
Updated: Jan 21, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
Tohru Tani1,2, Tomoharu Shimizu3, Masaji Tani3
1Biomedical Innovation Center, Shiga University of Medical Science, Otsu, Shiga, Japan. tan@belle.shiga-med.ac.jp.
Abstract:
Polymyxin B is an antibiotic that shows strong bactericidal activity against Gram-negative bacteria, by binding to and inactivating endotoxin. Systemic administration of polymyxin B in humans is restricted because of its nephrotoxicity and neurotoxicity, and this compound was therefore considered a strong candidate ligand for the extracorporeal selective adsorption of circulating endotoxin in the blood. Toraymyxin® is a direct hemoperfusion column that uses polymyxin B attached to an insoluble carrier to bind endotoxin in the blood. In 1994, the Japanese National Health Insurance system approved the use of Toraymyxin for the treatment of endotoxemia and septic shock.In this chapter, we will review the development, clinical use, and efficacy of Toraymyxin, examine the structure of the Toraymyxin column, and comment on the current position of Toraymyxin in the treatment of severe sepsis and septic shock. We will also highlight some potential new applications of Toraymyxin for pulmonary diseases.
Insights
Polymyxin B hemoperfusion via Toraymyxin effectively removes endotoxin, offering a treatment for endotoxemia and septic shock. This method bypasses systemic toxicity, with potential applications in pulmonary diseases.
Area of Science:
- Pharmacology
- Nephrology
- Critical Care Medicine
Background:
- Polymyxin B exhibits potent bactericidal activity against Gram-negative bacteria by targeting endotoxin.
- Systemic polymyxin B use is limited by nephrotoxicity and neurotoxicity.
- Extracorporeal endotoxin adsorption is a potential therapeutic strategy.
Purpose of the Study:
- To review the development, clinical use, and efficacy of Toraymyxin, a polymyxin B-based hemoperfusion column.
- To examine the structure and mechanism of the Toraymyxin column.
- To discuss the current role and potential new applications of Toraymyxin.
Main Methods:
- Direct hemoperfusion utilizing polymyxin B immobilized on an insoluble carrier.
- Clinical application for endotoxemia and septic shock treatment.
- Review of historical data, clinical use, and efficacy.
Main Results:
- Toraymyxin selectively binds and removes endotoxin from blood.
- Approved in Japan since 1994 for endotoxemia and septic shock.
- Demonstrated efficacy in managing severe sepsis and septic shock.
Conclusions:
- Toraymyxin provides a safe and effective method for endotoxin removal, mitigating systemic toxicity.
- Established treatment for endotoxemia and septic shock in Japan.
- Emerging potential for treating pulmonary diseases warrants further investigation.
Related Concept Videos
Classification of Skeletal Muscle Fibers
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Physical and Chemical Properties of Matter
Properties of Transition Metals
Convolution Properties I
The commutative property reveals that the input and the impulse response of an LTI (Linear Time-Invariant) system can be interchanged without affecting the output:
Properties of DTFT II
The frequency differentiation property is illustrated by considering a DTFT pair and differentiating both sides with respect to ω.
Properties of the z-Transform I

